Search
01/01/2023
PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries
Langenbruch A., Mohr N., Andrees V., Kessens I., Reich A., Czarnecka-Operacz M., Puig L., Dauden E., Iversen L., Augustin M.. PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries. ACTA DERMATO-VENEREOLOGICA. 2023; 103DOI:10.2340/actadv.v103.6532. PMID:37649411. IF:3.500(Q1/3D).
01/01/2023
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Pereyra-Rodríguez J.-J., Herranz P., Ruiz-Villaverde R., Elosua-González M., Galán-Gutiérrez M., Figueras-Nart I., Miquel J., de la Cueva P., Serra-Baldrich E., Munera-Campos M., Melé-Ninot G., Expósito-Serrano V., Perez B., Serrano A., Ortiz de Frutos J.F., Armario-Hita J.C.. Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2023; 48(9)DOI:10.1093/ced/llad153. PMID:37098171. IF:3.700(Q1/2D).
01/01/2023
Genetic and Epigenetic Mechanisms of Psoriasis
Mateu-Arrom L., Puig L.. Genetic and Epigenetic Mechanisms of Psoriasis. Genes. 2023; 14(8)DOI:10.3390/genes14081619. PMID:37628670. IF:2.800(Q2/5D).
01/01/2023
The biological basis of disease recurrence in psoriasis
Carmona-Rocha E., Puig L.. The biological basis of disease recurrence in psoriasis. Italian Journal of Dermatology and Venereology. 2023; 158(4)DOI:10.23736/S2784-8671.23.07583-7. PMID:37404193. IF:1.800(Q3/6D).